The European Medicines Agency (EMA) announced on Wednesday that it has begun negotiations with the manufacturers of Russia’s pioneering Sputnik V coronavirus vaccine.
According to an official from the EU body, which licenses medicines and vaccines within the bloc, “the developer has contacted EMA and they are in early discussions now.” Regulators will assess data on Sputnik V before publishing a recommendation on whether it can be used by healthcare systems within EU member states.
Continue reading https://on.rt.com/avu4